Stocks › EVH

Evolent Health, Inc.

EVH·NYSE·United States United States·USD
$3.90
+0.47 (+13.70%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
EVH
Evolent Health, Inc. · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
EVHS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of EVH by members of U.S. Congress · 7 on record
All congressional trades →
PoliticianStockTypeFiledTraded
Greg GianforteGreg GianforteHouse · R · MT EVHEvolent Health, Inc. · Stock Sale
$50,001 - $100,000
May 29, 2020 May 11, 2020 Filing ↗
Greg GianforteGreg GianforteHouse · R · MT EVHEvolent Health, Inc. · Stock Purchase
$100,001 - $250,000
Nov 27, 2019 Oct 11, 2019 Filing ↗
Greg GianforteGreg GianforteHouse · R · MT EVHEvolent Health, Inc. · Stock Sale
$50,001 - $100,000
Oct 20, 2019 Sep 10, 2019 Filing ↗
Greg GianforteGreg GianforteHouse · R · MT EVHEvolent Health, Inc. · Stock Purchase
$15,001 - $50,000
Jan 23, 2019 Dec 20, 2018 Filing ↗
Greg GianforteGreg GianforteHouse · R · MT EVHEvolent Health, Inc. · Stock Purchase
$50,001 - $100,000
Jun 15, 2018 Jun 7, 2018 Filing ↗
Greg GianforteGreg GianforteHouse · R · MT EVHEvolent Health, Inc. · Stock Purchase
$15,001 - $50,000
Feb 8, 2018 Jan 29, 2018 Filing ↗
Greg GianforteGreg GianforteHouse · R · MT EVHEvolent Health, Inc. · Stock Sale
$15,001 - $50,000
Jan 4, 2018 Dec 29, 2017 Filing ↗

Whale Activity

Position changes in EVH reported for 2026-09-30 by 224 institutional filers
Increased: 67New: 28Held: 27Decreased: 63Closed: 31No prior filing: 8
  • Increased67
  • New28
  • Held27
  • Decreased63
  • Closed31
  • No prior filing8
FilerSharesValueChange
BlackRock, Inc.15.8M$55.1Mincreased
Rubicon Founders LLC5.6M$19.7Mdecreased
MARSHALL WACE, LLP5.3M$18.6Mincreased
Engaged Capital LLC5.0M$17.6Mdecreased
VANGUARD CAPITAL MANAGEMENT LLC4.7M$16.3Mdecreased
Nuveen, LLC3.9M$13.6Mincreased
TWO SIGMA INVESTMENTS, LP3.4M$11.9Mincreased
D. E. Shaw & Co., Inc.3.4M$11.8Mdecreased
VANGUARD PORTFOLIO MANAGEMENT LLC3.3M$11.7Mincreased
NOMURA HOLDINGS INC3.0M$10.5Mnew
GLENMEDE TRUST CO NA1.2M$10.0Mnew
STATE STREET CORP2.5M$8.8Mincreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by EVH insiders, by quarter · Form 4
-200.0K-100.0K0100.0K200.0K2025 Q1: 148.0K2025 Q12025 Q2: 02025 Q22025 Q3: 02025 Q32025 Q4: 10.0K2025 Q42026 Q1: 02026 Q12026 Q2: 02026 Q22026 Q3: -65.9K2026 Q32026 Q4: 02026 Q4

Recent Insider Transactions

633 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
McCarthy Daniel JosephPRESIDENT Sale −65.9K $5.00 $329K Aug 26, 2026 Form 4 ↗
Weinberg JonathanGeneral Counsel Tax withholding −2,650 $5.74 $15K Jul 1, 2026 Form 4 ↗
Weinberg JonathanGeneral Counsel Grant / award +43.1K $0.00 $0 Jul 1, 2026 Form 4 ↗
Blackley SethChief Executive Officer · Director Tax withholding −10.3K $5.74 $59K Jul 1, 2026 Form 4 ↗
Blackley SethChief Executive Officer · Director Grant / award +446.1K $0.00 $0 Jul 1, 2026 Form 4 ↗
McCarthy Daniel JosephPRESIDENT Tax withholding −4,582 $5.74 $26K Jul 1, 2026 Form 4 ↗
McCarthy Daniel JosephPRESIDENT Grant / award +302.6K $0.00 $0 Jul 1, 2026 Form 4 ↗
Shams AammaadChief Accounting Officer Grant / award +28.8K $0.00 $0 Jul 1, 2026 Form 4 ↗
Ajayi ToyinDirector Grant / award +41.1K $0.00 $0 Jun 4, 2026 Form 4 ↗
Glass Russell MonroeDirector Grant / award +41.1K $0.00 $0 Jun 4, 2026 Form 4 ↗
GRUA PETER JDirector Grant / award +41.1K $0.00 $0 Jun 4, 2026 Form 4 ↗
GUERTIN SHAWN MDirector Grant / award +41.1K $0.00 $0 Jun 4, 2026 Form 4 ↗
Jelinek Richard MDirector Grant / award +41.1K $0.00 $0 Jun 4, 2026 Form 4 ↗
KECK KIMDirector Grant / award +41.1K $0.00 $0 Jun 4, 2026 Form 4 ↗
Smith Jill D.Director Grant / award +41.1K $0.00 $0 Jun 4, 2026 Form 4 ↗
Springstubb Brendan BDirector Grant / award +41.1K $0.00 $0 Jun 4, 2026 Form 4 ↗
Barbarosh Craig A.Director Grant / award +41.1K $0.00 $0 Jun 4, 2026 Form 4 ↗
Weinberg JonathanGeneral Counsel Tax withholding −8,275 $3.51 $29K Mar 3, 2026 Form 4 ↗
Blackley SethChief Executive Officer · Director Tax withholding −24.1K $3.51 $84K Mar 3, 2026 Form 4 ↗
McCarthy Daniel JosephPRESIDENT Tax withholding −24.0K $3.51 $84K Mar 3, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding EVH · SEC Form N-PORT
FundSharesValue% of fundAs of
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
3.4M$18.3M0.00%Jun 30, 2026
iShares Russell 2000 ETF
iShares Trust
3.0M$16.0M0.02%Jun 30, 2026
VANGUARD EXTENDED MARKET INDEX FUND
VANGUARD INDEX FUNDS
1.3M$7.0M0.01%Jun 30, 2026
BlackRock Advantage Small Cap Core Fund
BlackRock Funds
1.5M$6.5M0.12%Aug 31, 2026
Nuveen Quant Small Cap Equity Fund
TIAA-CREF Funds
1.4M$4.4M0.11%Jul 31, 2026
Schwab Fundamental U.S. Small Company ETF
SCHWAB STRATEGIC TRUST
914.1K$4.1M0.05%Aug 31, 2026
Fidelity Small Cap Index Fund
Fidelity Salem Street Trust
1.3M$3.9M0.01%Jul 31, 2026
iShares Russell 2000 Value ETF
iShares Trust
688.0K$3.7M0.03%Jun 30, 2026
College Retirement Equities Fund - Total Global Stock Account
College Retirement Equities Fund
574.0K$3.1M0.00%Jun 30, 2026
VANGUARD RUSSELL 2000 INDEX FUND
VANGUARD SCOTTSDALE FUNDS
655.8K$3.0M0.02%Aug 31, 2026

Mutual funds and ETFs whose N-PORT filings list EVH's shares (CUSIP 30050B101), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • Eric BannaschSCHEDULE 13G/A · passive (13G) · 509.5K shares0.5%
    Nov 16, 2026 · ↗
  • Cadian Capital Management GP, LLCSCHEDULE 13G/A · passive (13G) · 509.5K shares0.5%
    Nov 16, 2026 · ↗
  • Cadian Capital Management, LPSCHEDULE 13G/A · passive (13G) · 509.5K shares0.5%
    Nov 16, 2026 · ↗
  • Boehler AdamSCHEDULE 13G/A · passive (13G) · 5.6M shares5.0%
    Nov 13, 2026 · ↗
  • Rubicon Founders LLCSCHEDULE 13G/A · passive (13G) · 5.6M shares5.0%
    Nov 13, 2026 · ↗
  • Rubicon OP GP II LLCSCHEDULE 13G/A · passive (13G) · 5.6M shares5.0%
    Nov 13, 2026 · ↗
  • Rubicon OP GP II LPSCHEDULE 13G/A · passive (13G) · 5.6M shares5.0%
    Nov 13, 2026 · ↗
  • Rubicon Fund II PF LPSCHEDULE 13G/A · passive (13G) · 693.7K shares0.6%
    Nov 13, 2026 · ↗
  • Rubicon Fund II LPSCHEDULE 13G/A · passive (13G) · 4.9M shares4.4%
    Nov 13, 2026 · ↗
  • Morgan Stanley Capital Services LLCSCHEDULE 13G/A · passive (13G) · 2.9M shares2.5%
    Sep 8, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming Evolent Health, Inc. as client

No lobbying filings found naming Evolent Health, Inc. as the client.

Government Contracts

Federal awards to Evolent Health, Inc. · USAspending

No federal contract awards found for Evolent Health, Inc..

U.S. Patents

Recent USPTO applications naming Evolent Health, Inc.

No USPTO patent applications found for Evolent Health, Inc..

Annual Financials

From EVH's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$1.88B$2.55B$1.96B$1.35B$908.0M
Operating income-$410.1M-$40.5M-$71.2M$3.6M-$42.4M
Net income-$534.5M-$61.6M-$113.0M-$19.2M-$37.6M
Diluted EPS-$5.07-$0.81-$1.28-$0.20-$0.44
Operating cash flow$38.8M$18.8M$142.6M-$11.6M$38.7M
Cash and equivalents$151.9M$104.2M$192.8M$188.2M$266.3M
Total assets$1.90B$2.54B$2.68B$1.82B$1.42B
Total liabilities$1.48B$1.35B$1.43B$957.9M$725.8M
Shareholders' equity$415.2M$1.00B$1.07B$859.4M$693.6M

As Evolent Health, Inc. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 25, 2026 ↗

Stock Splits

Every split and reverse split in the price history

No stock splits in EVH's price history.

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 2.02, 9.01Results of operationsNov 5, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsAug 6, 2026
    EDGAR ↗
  • 8-K · Items 5.07Shareholder voteJun 4, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsMay 7, 2026
    EDGAR ↗

About Evolent Health, Inc.

From SEC EDGAR company records
Industry (SIC 8741)Services-Management Services
SectorIndustrials
HeadquartersARLINGTON, VA
IncorporatedDE